Today: January 22, 2019, 1:40 am

Pharmascroll launches Market intelligence reports on disease indications

Pharmascroll to offer Monthly Market Intelligence reports on multiple disease indications both on a standalone and subscription basis.
Pharmascroll Research and Consulting Private Limited
Pharmascroll Research and Consulting Private Limited 2018-05-08 06:21:17
Pharmascroll, a Pharmaceutical market research and business consulting firm, would be offering Monthly Market Intelligence reports on multiple disease indications both on a standalone and subscription basis. Pharmascroll launched its operations in June 2017, and since then has been offering quality Market Research services in various disease indications. The company on the back of its successful engagement with Market Research clients and superior research and competitive tracking capabilities across indications has now decided to offer Market intelligence reports monthly.

“Pharmascroll understands that because of the increasing research and commercialization spends, on Pharmaceutical drugs, incurred by the firms, it becomes imperative for the firms to keep a close watch on the competitor activities in the market and prepare well in advance to gain or retain majority share in the market. Pharmascroll, attributed to its extensive research capabilities, can help the firms track the competition by providing timely alerts of the competitor activities and their potential implications as well as help the firms apprise themselves of the evolving market trends and innovations in the disease area of interest.”, says Bhawna Gupta, Director, Pharmascroll.

Major Sections of the reports:

Disease Indication Overview

This section gives the overview of the disease indication in detail. The section highlights the basic definition, causes and symptoms of disease, profile of patients and multiple methods through which the patient can be diagnosed for the disease.

Market Intelligence Information Overview and Potential Implications

The reports cover in detail the following market updates in the form of major research events in the disease area of interest

• Detailed Congress coverage and events updates

• Clinical Trial results and updates

• Latest Research findings from scientific institutions and observational/interventional studies

• Regulatory bodies updates

• Patients and Physicians findings from multiple sources

• Latest updates related to drugs and other activities from Companies, operating and researching in the disease indication which further include

o Drug approval events

o Clinical updates for drugs including new Safety and Regulatory warnings from Regulatory bodies

o Promotional activities

o Investor events

o Mergers and Acquisitions details

The reports further detail the potential implications of every event covered, on the Market and the Pharmaceutical firms researching or marketing their drugs in the disease area, both in short-term and long-term. This in turn would enable firms to keep a close watch on the competitor drugs in the market and prepare well in advance for the implications of competitor activities to gain or retain majority share in the market

Disease Indications covered:

Pharmascroll further announced that the reports would be available across multiple indications in the disease areas as mentioned.

• Neurology and Psychiatry Indications (Migraine, MS, Bipolar disorders, Alzheimer’s disease, Epilepsy, Parkinson’s Disease)

• Cardiovascular Indications (ACS, HF, Hypertension)

• Respiratory Indications (Asthma, COPD, CF, IPF, Allergic Rhinitis)

• Oncology Indications

• Gastro-Intestinal Indications

• Immunology Indications (Rheumatoid Arthritis, Psoriasis, Lupus)

• Dermatology disorders (Acne, Atopic Dermatitis, Urtecaria)

• Metabolic disorders (Diabetes, Obesity, Dyslipidemia)

• Musculoskeletal Indications (Osteoporosis)

• Blood related disorders

• Infectious Diseases (HIV, Hepatitis C, Influenza)

• Hormonal disorders

• Reproduction related disorders

• Surgical procedures

• Renal disorders

• Rare Diseases

• Vaccines

Pharmascroll can be reached out at or at +919776868067 for any queries or discussions. To know more details about the company visit

Press Information
Pharmascroll Research and Consulting Pvt Ltd
Hi Tech City, Hyderabad, India, Zip- 500084

Bhawna Gupta

# 544 Words
Related Articles
More From The Author
PPMS and SPMS: Epidemiology and Market Forecasts [..]
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves [..]
More From Health
New in Neuro science Creativity - New [..]
Some people might not receive any results. They won't get results because they do not stay consistent in going through [..]
Medical Licensing Council (MLC) publicly rebukes the [..]
After 12 Consecutive Months of Substantial Clinical Studies and Intensive Hybrid Learning , Hundreds of Medical School Dropouts from [..]
Top Tips on How to Maintain Your [..]
[18 jan 19, Mumbai] Obesity has become a worldwide problem today and there are millions affected by this problem. The [..]
Best Hospitals in India empanel with Forerunners [..]
17 Jan 2019, Delhi Numerous Medical Tourists easily accessing Best Hospitals in India empanel with Forerunners Healthcare Consultants [..]
Gamma Knife Surgery in India offer high [..]
India offers high Quality and affordable treatment at affordable cost including the Low-cost Gamma knife surgery India. There [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.